Does TADALAFIL Cause Injection site haemorrhage? 22 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 22 reports of Injection site haemorrhage have been filed in association with TADALAFIL (Esokalli Testosterone Booster Oral Dissolving Film). This represents 0.1% of all adverse event reports for TADALAFIL.
22
Reports of Injection site haemorrhage with TADALAFIL
0.1%
of all TADALAFIL reports
0
Deaths
8
Hospitalizations
How Dangerous Is Injection site haemorrhage From TADALAFIL?
Of the 22 reports, 8 (36.4%) required hospitalization.
Is Injection site haemorrhage Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TADALAFIL. However, 22 reports have been filed with the FAERS database.
What Other Side Effects Does TADALAFIL Cause?
Headache (3,196)
Drug ineffective (2,943)
Dyspnoea (2,881)
Death (1,917)
Diarrhoea (1,667)
Dizziness (1,374)
Nausea (1,368)
Asthenia (1,230)
Fatigue (1,135)
Hypertension (1,044)
What Other Drugs Cause Injection site haemorrhage?
ADALIMUMAB (11,715)
EXENATIDE (5,527)
ETANERCEPT (4,674)
TIRZEPATIDE (4,389)
EVOLOCUMAB (3,720)
DULAGLUTIDE (3,028)
TERIPARATIDE (2,330)
GALCANEZUMAB-GNLM (1,415)
DUPILUMAB (1,401)
HUMIRA (1,304)
Which TADALAFIL Alternatives Have Lower Injection site haemorrhage Risk?
TADALAFIL vs TAFAMIDIS
TADALAFIL vs TAFAMIDIS MEGLUMINE
TADALAFIL vs TAFASITAMAB
TADALAFIL vs TAFASITAMAB-CXIX
TADALAFIL vs TAFINLAR